Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05175248 · ClinicalTrials.gov registry record · NA
Nutritional Intervention for Endometriosis
A NA study of Endometriosis, sponsored by Physicians Committee for Responsible Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05175248: Recruiting NA study of Endometriosis, sponsored by Physicians Committee for Responsible Medicine.
NCT05175248 is a NA study of Endometriosis that is actively recruiting participants, run by Physicians Committee for Responsible Medicine. The registered enrollment target is 120 participants, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05175248, a NA study of Endometriosis, is actively recruiting participants, sponsored by Physicians Committee for Responsible Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
In a 12-week parallel study, women with a verified diagnosis of endometriosis will be randomly assigned to follow a low-fat plant-based diet or to stay on their usual diets for 12 weeks. Participants in both groups will be asked to make no changes to their exercise patterns for the study period. Changes in pain, quality of life, and inflammatory biomarkers from baseline to final will be the primary outcomes. Secondary outcomes will include changes in body weight, blood lipids, gut microbiome composition, and hormonal changes.
Primary Outcome
Endometriosis-specific pain scale will be used. For inclusion in study, participants require a score of at least 5/9.
Conditions Studied
Interventions
- BEHAVIORAL Plant-based Intervention Group
Study Locations (1)
District of Columbia
- Physicians Committee for Responsible Medicine - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05175248 shows while recruiting
NCT05175248 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 1 intervention - of which Plant-based Intervention Group is the first listed.
NCT05175248 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05175248 about?
NCT05175248 is a clinical study titled "Nutritional Intervention for Endometriosis". In a 12-week parallel study, women with a verified diagnosis of endometriosis will be randomly assigned to follow a low-fat plant-based diet or to stay on their usual diets for 12 weeks. Participants in both groups will be asked to make no changes to their exercise patterns for the study period. Cha...
What is the current status of trial NCT05175248?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-03-02. Estimated completion is 2026-12.
What conditions does trial NCT05175248 study?
This clinical trial studies the following conditions: Endometriosis.
What interventions are being tested in trial NCT05175248?
The interventions under investigation include: Plant-based Intervention Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05175248?
This trial is sponsored by Physicians Committee for Responsible Medicine, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05175248 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05175248's enrollment target sits among peer trials
120 18th of 48 higher than 27 of 48 other Endometriosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometriosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
-
The Impact of Yoga on Endometriosis-Related Pain
RECRUITING · NA
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
-
Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
RECRUITING · NA
-
Histologic Comparison of Ablative Techniques for Endometriosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI